5 Most Valuable Biotech Companies in the World

3. Pfizer Inc. (NYSE: PFE)

Market Cap: $234.039 billion
Number of Hedge Fund Holders: 65

Pfizer Inc. (NYSE: PFE) produces vaccines and other medicines for cardiology, neurology, oncology, endocrinology, and immunology. The company has several popular products which generate more than a billion dollars in revenue each year. The foundation of their research and production activities is biotech. Pfizer Inc. (NYSE: PFE) has recently produced 430 million doses of the COVID-19 vaccine in collaboration with BioNTech which have been distributed worldwide to combat the pandemic. Over 3 billion doses of this vaccine are expected to be produced by the end of 2021. Pfizer Inc. (NYSE: PFE) has also announced that it will invest up to $500 million in biotech companies to continue its clinical development programs through the Pfizer Breakthrough Initiative. With a market cap of $234.04 billion, Pfizer Inc. (NYSE: PFE) ranks third in the list of the 15 most valuable biotech companies in the world.